Report cover image

Stem Cells Market, By Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Natural Rosette Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development), By Technology (

Publisher Coherent Market Insights
Published May 05, 2022
Length 187 Pages
SKU # CMI17212618

Description

Stem Cells Market, By Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Natural Rosette Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.
Restraints of the Global Stem Cells Market
Major factors hampering the growth of the stem cells market during the forecast period constitutes of high costs, and lack of skilled professionals.
Key features of the study:
This report provides in-depth analysis of the global stem cells market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global stem cells market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Stem Cells Market, By Type:
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
Global Stem Cells Market, By Application:
Regenerative Medicine
Drug Discovery and Development
Global Stem Cells Market, By Technology:
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
Global Stem Cells Market, By Geography:
North America
By Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
By Application
Regenerative Medicine
Drug Discovery and Development
By Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
By Country:
U.S.
Canada
Europe
By Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
By Application
Regenerative Medicine
Drug Discovery and Development
By Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
By Application
Regenerative Medicine
Drug Discovery and Development
By Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
By Application
Regenerative Medicine
Drug Discovery and Development
By Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
By Application
Regenerative Medicine
Drug Discovery and Development
By Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
By Application
Regenerative Medicine
Drug Discovery and Development
By Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Advanced Cell Technology, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Angel Biotechnology Holdings PLC
Bioheart Inc.
Lineage Cell Therapeutics
BrainStorm Cell Therapeutics, Inc.
California Stem Cell Inc.
Celgene Corporation
Takara Bio Europe AB
Cellular Engineering Technologies
Cytori Therapeutics Inc.
Osiris Therapeutics
STEMCELL Technologies Inc
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

187 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Application
Market Snippet, By Technology
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact Analysis
4. Global Stem Cells Market, By Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Adult Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Human Embryonic Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Induced Pluripotent Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Natural Rosette Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Very Small Embryonic Like Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
5. Global Stem Cells Market, By Application, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Regenerative Medicine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Drug Discovery and Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Stem Cells Market, By Technology, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Cell Acquisition
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Cell Production
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Cryopreservation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Expansion and Sub-Culture
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Stem Cells Market, By Regions, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Advanced Cell Technology, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Angel Biotechnology Holdings PLC
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bioheart Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Lineage Cell Therapeutics
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BrainStorm Cell Therapeutics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
California Stem Cell Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Celgene Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Takara Bio Europe AB
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cellular Engineering Technologies
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cytori Therapeutics Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Osiris Therapeutics
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
STEMCELL Technologies Inc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 24 figures on “Stem Cells Market – Global forecast to 2028.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us